The Union for International Cancer Control's (UICC) rapidly increasing membership base of over 1200 organisations in 172 countries, represents the world’s major cancer societies, ministries of health and patient groups and includes influential policy makers, researchers and experts in cancer prevention and control. UICC also boasts more than 50 strategic partners.
In the last decade, we have reached millions of people with World Cancer Day, welcomed more than 15,000 delegates at our World Cancer Congresses, and launched four new organisations: the International Cancer Control Partnership, the McCabe Centre for Law & Cancer, City Cancer Challenge Foundation and the NCD Alliance.
Founded in 1951, the Swedish Cancer Society is an independent non-profit organization. Its main task is to raise and distribute money for cancer research. The core of the Swedish Cancer Society's activities is funding research. The Swedish Cancer Society funds research projects, care development projects, in cancer research positions, grants and other areas. Additional areas of support include participation in courses and conferences related to cancer, as well as scientific meetings and collaboration groups. The crucial aspects when awarding grants are each project's originality, anticipated news value and feasibility, and its link to cancer. The process of selecting the very best research projects follows established procedures and is closely regulated. Regulations stipulate that the Research Commission should follow the same principles as government research councils - such as the national Swedish Research Council - when awarding grants. The Research Commission's aim is to support the projects that represent the highest quality in the field of cancer, whatever the focus. This means that selection takes place in national competition and does not take account of the field of research or geographic location. However, there are some exceptions where targeted funds are awarded to research areas of particular urgency. Swedish Cancer Society has been a UICC full member since 1967.
The HUG: Care, Teaching, and leading-edge Research
The Geneva University Hospital (HUG) comprises eight public hospitals and two clinics. Theirs missions are to provide health care to the community in all medical specialties, to help train physicians and health professionals, and to conduct medical and clinical research. The HUG operate as a national reference centre for influenza, emerging viral infections, meningococcus, and transplant immunology, and are the national reference laboratory for histocompatibility. They are also a WHO Collaborating Centre in six areas, as well as Centres of Excellence in a number of sectors. The HUG treat 275,000 patients each year, with a capacity of 2,015 hospital beds, and employ 12.800 people.
For more information on publications visit https://www.hug.ch/publications-hug
www.hug.ch – presse-hug@hcuge.ch
References:
https://www.hug.ch/laboratoire-virologie/centre-national-reference-influenza-cnri
https://www.hug.ch/centre-maladies-virales-emergentes
http://www.meningo.ch/
https://www.hug.ch/nephrologie/unite-immunologie-transplantation
https://www.hug.ch/en-bref
https://www.hug.ch/centres
